๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Vogt-Koyanagi-Harada disease occurring during interferon alpha therapy for chronic hepatitis C

โœ Scribed by Akinori Kasahara; Atsushi Hiraide; Naruya Tomita; Hiromi Iwahashi; Akihisa Imagawa; Nobuyuki Ohguro; Shuji Yamamoto; Eiji Mita; Norio Hayashi

Publisher
Springer Japan
Year
2004
Tongue
English
Weight
146 KB
Volume
39
Category
Article
ISSN
0944-1174

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Autoantibodies during ฮฑ-interferon thera
Autoantibodies during ฮฑ-interferon therapy for chronic hepatitis B
โœ G. Fattovich; C. Betterle; L. Brollo; B. Pedini; G. Giustina; G. Realdi; A. Albe ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 424 KB

The development of autoantibodies and autoimmune reactions has been reported during and after interferon (IFN) therapy. Thirteen different antibodies from the sera of 32 patients with chronic hepatitis B treated with alpha-interferon (alpha-IFN) were tested. Seventeen HBeAg-positive patients receive

Changes in serum fibrogenesis markers du
Changes in serum fibrogenesis markers during interferon therapy for chronic hepatitis type C
โœ K Ishibashi; T Kashiwagi; A Ito; Y Tanaka; M Nagasawa; T Toyama; S Ozaki; M Nait ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 203 KB

the changes in serum levels of hepatic fibrogenesis markers We serially measured the levels of serum N-terminal caused by interferon therapy for chronic hepatitis. 9,10 peptide of type III procollagen (PIIINP), the 7S domain In this study, the serum levels of PIIINP, IV-7S, and HA of type IV collag